2009
DOI: 10.4077/cjp.2009.amh004
|View full text |Cite
|
Sign up to set email alerts
|

Enhancement of AG1024-Induced H9c2 Cardiomyoblast Cell Apoptosis via the Interaction of IGF2R with Gα Proteins and Its Downstream PKA and PLC-β Modulators by IGF-Ⅱ

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
15
0

Year Published

2011
2011
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 13 publications
(15 citation statements)
references
References 27 publications
0
15
0
Order By: Relevance
“…The IGF‐2R has previously been linked to the Gi 2 (Nishimoto, 1993) and Gαq (Chu et al 2008) subunit signalling, where both were associated with cardiac hypertrophy (Böhm et al 1994; D’Angelo et al 1997). In an in vitro cardiomyocyte study of apoptosis, IGF‐2R activation resulted in decreased PKA protein expression (Chu et al 2009 a ), but no previous studies have shown a link between the IGF‐2R and cardiomyocyte hypertrophy involving Gαs signalling. Therefore our finding that IGF‐2R activation can cause cardiomyocyte hypertrophy in vivo , in a Gαs signalling‐dependent manner, is novel and this signalling could have potential implications for cardiac pathogenesis.…”
Section: Discussionmentioning
confidence: 99%
“…The IGF‐2R has previously been linked to the Gi 2 (Nishimoto, 1993) and Gαq (Chu et al 2008) subunit signalling, where both were associated with cardiac hypertrophy (Böhm et al 1994; D’Angelo et al 1997). In an in vitro cardiomyocyte study of apoptosis, IGF‐2R activation resulted in decreased PKA protein expression (Chu et al 2009 a ), but no previous studies have shown a link between the IGF‐2R and cardiomyocyte hypertrophy involving Gαs signalling. Therefore our finding that IGF‐2R activation can cause cardiomyocyte hypertrophy in vivo , in a Gαs signalling‐dependent manner, is novel and this signalling could have potential implications for cardiac pathogenesis.…”
Section: Discussionmentioning
confidence: 99%
“…In the heart, the IGF-IIR disruption leads to cellular protection against cardiomyocyte apoptosis (Chen et al, 2004) and IGF-II and IGF-IIR up regulation in cardiomyocytes have been identified in a variety of heart disease models (Lee et al, 2006;Chang et al, 2008;Chu et al, 2008Chu et al, , 2009b. IGF-IIR could also function as a G proteincoupled receptor to trigger its downstream signaling modulators such as PKC-a/CaMKII, calcineurin and MMP/ TIMP, contributing to heart failure progression (Chang et al, 2008;Chu et al, 2008Chu et al, , 2009aChen et al, 2009). The upregulation of IGF-IIR gene expression occurred in this study after treatment with ANGII, LPS, inomycin, and TNF-a (Fig.…”
Section: Discussionmentioning
confidence: 99%
“…Activation of IGF2R, a Gαq receptor, induces cardiac hypertrophy, through the activation of downstream effectors such as Ca 2+ –calmodulin‐dependent protein kinase II (CAMKII), protein kinase C (PKC)‐α and protein kinase A (PKA) (Chu et al . , ; Wang et al . ).…”
Section: Introductionmentioning
confidence: 99%